Exact Mass: 596.428796

Exact Mass Matches: 596.428796

Found 42 metabolites which its exact mass value is equals to given mass value 596.428796, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

DG(13:0/5-iso PGF2VI/0:0)

(2S)-2-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-3-hydroxypropyl tridecanoate

C34H60O8 (596.4288)


DG(13:0/5-iso PGF2VI/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/5-iso PGF2VI/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(5-iso PGF2VI/13:0/0:0)

(2S)-1-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-3-hydroxypropan-2-yl tridecanoic acid

C34H60O8 (596.4288)


DG(5-iso PGF2VI/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(5-iso PGF2VI/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/5-iso PGF2VI)

(2R)-3-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-2-hydroxypropyl tridecanoic acid

C34H60O8 (596.4288)


DG(13:0/0:0/5-iso PGF2VI) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(5-iso PGF2VI/0:0/13:0)

(2S)-3-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-2-hydroxypropyl tridecanoic acid

C34H60O8 (596.4288)


DG(5-iso PGF2VI/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/5-iso PGF2VI/0:0)

(2S)-2-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-3-hydroxypropyl 10-methyldodecanoic acid

C34H60O8 (596.4288)


DG(a-13:0/5-iso PGF2VI/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/5-iso PGF2VI/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(5-iso PGF2VI/a-13:0/0:0)

(2S)-1-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-3-hydroxypropan-2-yl 10-methyldodecanoic acid

C34H60O8 (596.4288)


DG(5-iso PGF2VI/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(5-iso PGF2VI/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/5-iso PGF2VI)

(2R)-3-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-2-hydroxypropyl 10-methyldodecanoic acid

C34H60O8 (596.4288)


DG(a-13:0/0:0/5-iso PGF2VI) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(5-iso PGF2VI/0:0/a-13:0)

(2S)-3-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-2-hydroxypropyl 10-methyldodecanoic acid

C34H60O8 (596.4288)


DG(5-iso PGF2VI/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/5-iso PGF2VI/0:0)

(2S)-2-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-3-hydroxypropyl 11-methyldodecanoic acid

C34H60O8 (596.4288)


DG(i-13:0/5-iso PGF2VI/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/5-iso PGF2VI/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(5-iso PGF2VI/i-13:0/0:0)

(2S)-1-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-3-hydroxypropan-2-yl 11-methyldodecanoic acid

C34H60O8 (596.4288)


DG(5-iso PGF2VI/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(5-iso PGF2VI/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/5-iso PGF2VI)

(2R)-3-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-2-hydroxypropyl 11-methyldodecanoic acid

C34H60O8 (596.4288)


DG(i-13:0/0:0/5-iso PGF2VI) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(5-iso PGF2VI/0:0/i-13:0)

(2S)-3-{[(3Z)-5-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxyoct-1-en-1-yl]cyclopentyl]pent-3-enoyl]oxy}-2-hydroxypropyl 11-methyldodecanoic acid

C34H60O8 (596.4288)


DG(5-iso PGF2VI/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

Buxakashmiramine

Buxakashmiramine

C36H56N2O5 (596.4189)


   

Bacteriorubixanthinal

(3R)-9-cis-3-Hydroxy-1-methoxy-3,4-didehydro-1,2-dihydro-beta,psi-caroten-19-al

C41H56O3 (596.4229)


   

Sorangiolide B

Sorangiolide B

C34H60O8 (596.4288)


   

2-methoxy-1-hydroxy-beta,psi-caroten-4-one|3-deoxy-2-methoxyflexixanthin

2-methoxy-1-hydroxy-beta,psi-caroten-4-one|3-deoxy-2-methoxyflexixanthin

C41H56O3 (596.4229)


   

Xipholenin

(3S,3S,6R)-3-Methoxy-3-hydroxy-beta,epsilon-caroten-4-one

C41H56O3 (596.4229)


   

DG(13:0/5-iso PGF2VI/0:0)

DG(13:0/5-iso PGF2VI/0:0)

C34H60O8 (596.4288)


   

DG(5-iso PGF2VI/13:0/0:0)

DG(5-iso PGF2VI/13:0/0:0)

C34H60O8 (596.4288)


   

DG(13:0/0:0/5-iso PGF2VI)

DG(13:0/0:0/5-iso PGF2VI)

C34H60O8 (596.4288)


   

DG(5-iso PGF2VI/0:0/13:0)

DG(5-iso PGF2VI/0:0/13:0)

C34H60O8 (596.4288)


   

DG(a-13:0/5-iso PGF2VI/0:0)

DG(a-13:0/5-iso PGF2VI/0:0)

C34H60O8 (596.4288)


   

DG(5-iso PGF2VI/a-13:0/0:0)

DG(5-iso PGF2VI/a-13:0/0:0)

C34H60O8 (596.4288)


   

DG(a-13:0/0:0/5-iso PGF2VI)

DG(a-13:0/0:0/5-iso PGF2VI)

C34H60O8 (596.4288)


   

DG(5-iso PGF2VI/0:0/a-13:0)

DG(5-iso PGF2VI/0:0/a-13:0)

C34H60O8 (596.4288)


   

DG(i-13:0/5-iso PGF2VI/0:0)

DG(i-13:0/5-iso PGF2VI/0:0)

C34H60O8 (596.4288)


   

DG(5-iso PGF2VI/i-13:0/0:0)

DG(5-iso PGF2VI/i-13:0/0:0)

C34H60O8 (596.4288)


   

DG(i-13:0/0:0/5-iso PGF2VI)

DG(i-13:0/0:0/5-iso PGF2VI)

C34H60O8 (596.4288)


   

DG(5-iso PGF2VI/0:0/i-13:0)

DG(5-iso PGF2VI/0:0/i-13:0)

C34H60O8 (596.4288)


   
   

ST 28:0;O3;Hex

ST 28:0;O3;Hex

C34H60O8 (596.4288)


   

(3r,5s,6s,7s)-3-[(2s,3s,5s)-5-[(3s,4s,6r)-3,4-diethyl-6-methyl-2,7-dioxabicyclo[2.2.1]heptan-1-yl]-3,5-dimethyloxolan-2-yl]-7-[(2r,3s,4r,5r,6s)-5-ethyl-4,6-dihydroxy-3,6-dimethyloxan-2-yl]-6-hydroxy-5-methyloctan-4-one

(3r,5s,6s,7s)-3-[(2s,3s,5s)-5-[(3s,4s,6r)-3,4-diethyl-6-methyl-2,7-dioxabicyclo[2.2.1]heptan-1-yl]-3,5-dimethyloxolan-2-yl]-7-[(2r,3s,4r,5r,6s)-5-ethyl-4,6-dihydroxy-3,6-dimethyloxan-2-yl]-6-hydroxy-5-methyloctan-4-one

C34H60O8 (596.4288)


   

3-(24-hydroxy-23-methoxy-3,7,12,16,20,24-hexamethylpentacosa-1,3,5,7,9,11,13,15,17,19,21-undecaen-1-yl)-2,4,4-trimethylcyclohex-2-en-1-one

3-(24-hydroxy-23-methoxy-3,7,12,16,20,24-hexamethylpentacosa-1,3,5,7,9,11,13,15,17,19,21-undecaen-1-yl)-2,4,4-trimethylcyclohex-2-en-1-one

C41H56O3 (596.4229)


   

(4e,6e,8e,10e,12e,14e,16e)-17-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-2-(8-methoxy-4,8-dimethylnona-1,3,5-trien-1-yl)-6,11,15-trimethylheptadeca-2,4,6,8,10,12,14,16-octaenal

(4e,6e,8e,10e,12e,14e,16e)-17-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)-2-(8-methoxy-4,8-dimethylnona-1,3,5-trien-1-yl)-6,11,15-trimethylheptadeca-2,4,6,8,10,12,14,16-octaenal

C41H56O3 (596.4229)


   

6-hydroxy-11-(10,12,14-trihydroxy-3,7,9,13,17-pentamethyl-18-oxo-1-oxacyclooctadeca-8,16-dien-2-yl)dodecanoic acid

6-hydroxy-11-(10,12,14-trihydroxy-3,7,9,13,17-pentamethyl-18-oxo-1-oxacyclooctadeca-8,16-dien-2-yl)dodecanoic acid

C34H60O8 (596.4288)


   

(6s,11r)-6-hydroxy-11-[(2r,3s,7s,8e,10s,12r,13r,14r,16e)-10,12,14-trihydroxy-3,7,9,13,17-pentamethyl-18-oxo-1-oxacyclooctadeca-8,16-dien-2-yl]dodecanoic acid

(6s,11r)-6-hydroxy-11-[(2r,3s,7s,8e,10s,12r,13r,14r,16e)-10,12,14-trihydroxy-3,7,9,13,17-pentamethyl-18-oxo-1-oxacyclooctadeca-8,16-dien-2-yl]dodecanoic acid

C34H60O8 (596.4288)


   

3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e,19e,21e)-24-hydroxy-23-methoxy-3,7,12,16,20,24-hexamethylpentacosa-1,3,5,7,9,11,13,15,17,19,21-undecaen-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

3-[(1e,3e,5e,7e,9e,11e,13e,15e,17e,19e,21e)-24-hydroxy-23-methoxy-3,7,12,16,20,24-hexamethylpentacosa-1,3,5,7,9,11,13,15,17,19,21-undecaen-1-yl]-2,4,4-trimethylcyclohex-2-en-1-one

C41H56O3 (596.4229)


   

n-{15-[1-(dimethylamino)ethyl]-7-(hydroxymethyl)-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl}-4-hydroxy-3,5-dimethoxy-n-methylbenzamide

n-{15-[1-(dimethylamino)ethyl]-7-(hydroxymethyl)-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl}-4-hydroxy-3,5-dimethoxy-n-methylbenzamide

C36H56N2O5 (596.4189)


   

(3s,5s,6s,7s)-3-[(3s,5s)-5-[(3s,4s,6r)-3,4-diethyl-6-methyl-2,7-dioxabicyclo[2.2.1]heptan-1-yl]-3,5-dimethyloxolan-2-yl]-7-[(3s,4r,5r,6s)-5-ethyl-4,6-dihydroxy-3,6-dimethyloxan-2-yl]-6-hydroxy-5-methyloctan-4-one

(3s,5s,6s,7s)-3-[(3s,5s)-5-[(3s,4s,6r)-3,4-diethyl-6-methyl-2,7-dioxabicyclo[2.2.1]heptan-1-yl]-3,5-dimethyloxolan-2-yl]-7-[(3s,4r,5r,6s)-5-ethyl-4,6-dihydroxy-3,6-dimethyloxan-2-yl]-6-hydroxy-5-methyloctan-4-one

C34H60O8 (596.4288)


   

(11r)-6-hydroxy-11-[(2r,3s,7s,8z,10s,12r,13r,14r,16z)-10,12,14-trihydroxy-3,7,9,13,17-pentamethyl-18-oxo-1-oxacyclooctadeca-8,16-dien-2-yl]dodecanoic acid

(11r)-6-hydroxy-11-[(2r,3s,7s,8z,10s,12r,13r,14r,16z)-10,12,14-trihydroxy-3,7,9,13,17-pentamethyl-18-oxo-1-oxacyclooctadeca-8,16-dien-2-yl]dodecanoic acid

C34H60O8 (596.4288)


   

n-[(1s,3r,6s,7s,8r,11s,12s,15s,16r)-15-[(1s)-1-(dimethylamino)ethyl]-7-(hydroxymethyl)-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]-4-hydroxy-3,5-dimethoxy-n-methylbenzamide

n-[(1s,3r,6s,7s,8r,11s,12s,15s,16r)-15-[(1s)-1-(dimethylamino)ethyl]-7-(hydroxymethyl)-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]-4-hydroxy-3,5-dimethoxy-n-methylbenzamide

C36H56N2O5 (596.4189)